Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The Dosage of the Derivative of Clostridium Ghonii (DCG) Spores Dictates Whether an IFNγ/IL-9 or a Strong IFNγ Response Is Elicited in TC-1 Tumour Bearing Mice.

Ni G, Wang Y, Good D, Yuan J, Pan X, Wei J, Liu X, Wei MQ.

Biomed Res Int. 2019 Apr 28;2019:1395138. doi: 10.1155/2019/1395138. eCollection 2019.

2.

The tumour-Clostridium phenomenon: 50 years of developmental research (Review).

Schmidt W, Fabricius EM, Schneeweiss U.

Int J Oncol. 2006 Dec;29(6):1479-92. Review.

PMID:
17088987
3.

Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.

Mikysková R, Bubeník J, Vonka V, Smahel M, Indrova M, Bieblová J, Símová J, Jandlová T.

Int J Oncol. 2005 Feb;26(2):521-7.

PMID:
15645139
4.

Chemotherapy for tumours using clostridial oncolysis, antibiotics and cyclophosphamide: model trial on the UVT 15264 tumour.

Schlechte H, Schwabe K, Mehnert WH, Schulze B, Bräuniger H.

Arch Geschwulstforsch. 1982;52(1):41-8.

PMID:
7082130
6.

Measurement of specific multiplication of an oncolytic and a nononcolytic strain of Clostridium butyricum inside the tumour UVT 15264 of the mouse.

Schlechte H, Mehnert WH, Schulze B, Bräuniger H, Schwabe K.

Zentralbl Bakteriol Mikrobiol Hyg A. 1981;249(4):512-9.

PMID:
7032143
7.

Clostridial spores for cancer therapy: targeting solid tumour microenvironment.

Umer B, Good D, Anné J, Duan W, Wei MQ.

J Toxicol. 2012;2012:862764. doi: 10.1155/2012/862764. Epub 2012 Jun 7.

8.

Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-gamma signalling.

Rearden R, Sah A, Doff B, Kobayashi T, McKee SJ, Leggatt GR, Mattarollo SR.

Immunol Cell Biol. 2016 Jul;94(6):554-62. doi: 10.1038/icb.2016.9. Epub 2016 Jan 20.

PMID:
26786233
9.

Synthesized natural peptides from amphibian skin secretions increase the efficacy of a therapeutic vaccine by recruiting more T cells to the tumour site.

Pan X, Ma B, You X, Chen S, Wu J, Wang T, Walton SF, Yuan J, Wu X, Chen G, Wang Y, Ni G, Liu X.

BMC Complement Altern Med. 2019 Jul 6;19(1):163. doi: 10.1186/s12906-019-2571-z.

10.

Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.

Mikysková R, Indrová M, Símová J, Jandlová T, Bieblová J, Jinoch P, Bubeník J, Vonka V.

Int J Oncol. 2004 Jan;24(1):161-7.

PMID:
14654953
11.

Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects.

Indrová M, Reinis M, Bubeník J, Jandlová T, Bieblová J, Vonka V, Velek J.

Folia Biol (Praha). 2004;50(6):184-93.

12.

Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity.

Ding Y, Seow SV, Huang CH, Liew LM, Lim YC, Kuo IC, Chua KY.

Immunology. 2009 Sep;128(1 Suppl):e881-94. doi: 10.1111/j.1365-2567.2009.03099.x. Epub 2009 Mar 26.

13.

Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.

Indrová M, Bieblová J, Jandlová T, Vonka V, Pajtasz-Piasecka E, Reinis M.

Int J Oncol. 2006 Jan;28(1):253-9.

PMID:
16328003
14.

Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF.

Clin Cancer Res. 2014 Nov 1;20(21):5456-67. doi: 10.1158/1078-0432.CCR-14-0344. Epub 2014 Jun 3.

15.

Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model.

Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA.

J Clin Immunol. 2012 Dec;32(6):1353-9. doi: 10.1007/s10875-012-9708-x. Epub 2012 Jun 19.

PMID:
22711009
17.

Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.

Lee SY, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC.

J Mol Med (Berl). 2013 Oct;91(10):1221-31. doi: 10.1007/s00109-013-1054-9. Epub 2013 May 29.

18.

The use of clostridial spores for cancer treatment.

Barbé S, Van Mellaert L, Anné J.

J Appl Microbiol. 2006 Sep;101(3):571-8. Review.

19.

Chemotherapeutic tumour targeting using clostridial spores.

Minton NP, Mauchline ML, Lemmon MJ, Brehm JK, Fox M, Michael NP, Giaccia A, Brown JM.

FEMS Microbiol Rev. 1995 Oct;17(3):357-64. Review.

PMID:
7576773
20.

Supplemental Content

Support Center